MDS clinical diagnostic criteria for Parkinson's disease
- PMID: 26474316
- DOI: 10.1002/mds.26424
MDS clinical diagnostic criteria for Parkinson's disease
Abstract
This document presents the Movement Disorder Society Clinical Diagnostic Criteria for Parkinson's disease (PD). The Movement Disorder Society PD Criteria are intended for use in clinical research but also may be used to guide clinical diagnosis. The benchmark for these criteria is expert clinical diagnosis; the criteria aim to systematize the diagnostic process, to make it reproducible across centers and applicable by clinicians with less expertise in PD diagnosis. Although motor abnormalities remain central, increasing recognition has been given to nonmotor manifestations; these are incorporated into both the current criteria and particularly into separate criteria for prodromal PD. Similar to previous criteria, the Movement Disorder Society PD Criteria retain motor parkinsonism as the core feature of the disease, defined as bradykinesia plus rest tremor or rigidity. Explicit instructions for defining these cardinal features are included. After documentation of parkinsonism, determination of PD as the cause of parkinsonism relies on three categories of diagnostic features: absolute exclusion criteria (which rule out PD), red flags (which must be counterbalanced by additional supportive criteria to allow diagnosis of PD), and supportive criteria (positive features that increase confidence of the PD diagnosis). Two levels of certainty are delineated: clinically established PD (maximizing specificity at the expense of reduced sensitivity) and probable PD (which balances sensitivity and specificity). The Movement Disorder Society criteria retain elements proven valuable in previous criteria and omit aspects that are no longer justified, thereby encapsulating diagnosis according to current knowledge. As understanding of PD expands, the Movement Disorder Society criteria will need continuous revision to accommodate these advances.
Keywords: Parkinson's disease; absolute exclusion criteria; clinical diagnostic criteria; motor parkinsonism; non-motor manifestations; red flags; supportive criteria.
© 2015 International Parkinson and Movement Disorder Society.
Comment in
-
Parkinson disease. Unravelling the nonmotor mysteries of Parkinson disease.Nat Rev Neurol. 2016 Jan;12(1):10-1. doi: 10.1038/nrneurol.2015.236. Nat Rev Neurol. 2016. PMID: 26714657
-
Novel movement disorder society-Parkinson's disease criteria: What about SWEDD and genetic forms?Mov Disord. 2016 Mar;31(3):431. doi: 10.1002/mds.26538. Epub 2016 Feb 19. Mov Disord. 2016. PMID: 26893229 No abstract available.
-
Diagnosis of Parkinson's disease: Imaging and genetics.Mov Disord. 2016 Mar;31(3):431-2. doi: 10.1002/mds.26544. Epub 2016 Feb 22. Mov Disord. 2016. PMID: 26898197 No abstract available.
Similar articles
-
[New Diagnostic Criteria for Parkinson's Disease: MDS-PD Criteria].Brain Nerve. 2018 Feb;70(2):139-146. doi: 10.11477/mf.1416200966. Brain Nerve. 2018. PMID: 29433115 Review. Japanese.
-
Validation of the MDS clinical diagnostic criteria for Parkinson's disease.Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25. Mov Disord. 2018. PMID: 30145797
-
MDS research criteria for prodromal Parkinson's disease.Mov Disord. 2015 Oct;30(12):1600-11. doi: 10.1002/mds.26431. Mov Disord. 2015. PMID: 26474317 Review.
-
MDS clinical diagnostic criteria for Parkinson's disease in China.J Neurol. 2017 Mar;264(3):476-481. doi: 10.1007/s00415-016-8370-2. Epub 2016 Dec 26. J Neurol. 2017. PMID: 28025665
-
Isolated Cervical Dystonia: Diagnosis and Classification.Mov Disord. 2023 Aug;38(8):1367-1378. doi: 10.1002/mds.29387. Epub 2023 Mar 29. Mov Disord. 2023. PMID: 36989390 Free PMC article. Review.
Cited by
-
Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson's Disease.Front Neurosci. 2021 Mar 22;15:647168. doi: 10.3389/fnins.2021.647168. eCollection 2021. Front Neurosci. 2021. PMID: 33828454 Free PMC article.
-
Behind the Mask: Recognizing Facial Features of Parkinson's Disease During the COVID-19 Pandemic.Mov Disord. 2021 Jun;36(6):1285-1286. doi: 10.1002/mds.28619. Epub 2021 Apr 28. Mov Disord. 2021. PMID: 33834516 Free PMC article. No abstract available.
-
Older-onset levodopa-responsive parkinsonism with normal DAT-SPECT and pterin hypometabolism.BMJ Case Rep. 2021 May 7;14(5):e240067. doi: 10.1136/bcr-2020-240067. BMJ Case Rep. 2021. PMID: 33962918 Free PMC article.
-
Cricopharyngeal bar on videofluoroscopy: high specificity for inclusion body myositis.J Neurol. 2021 Mar;268(3):1016-1024. doi: 10.1007/s00415-020-10241-7. Epub 2020 Sep 26. J Neurol. 2021. PMID: 32980980
-
Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease.Front Neurol. 2020 Sep 2;11:897. doi: 10.3389/fneur.2020.00897. eCollection 2020. Front Neurol. 2020. PMID: 32982926 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous